These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 20823671)

  • 1. [Absorption of calcitonin in oral and pulmonary administration with polymer-coated liposomes].
    Takeuchi H; Sugihara H
    Yakugaku Zasshi; 2010 Sep; 130(9):1135-42. PubMed ID: 20823671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of submicron-sized, chitosan-coated liposomes in oral administration of peptide drugs.
    Takeuchi H; Matsui Y; Sugihara H; Yamamoto H; Kawashima Y
    Int J Pharm; 2005 Oct; 303(1-2):160-70. PubMed ID: 16125348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems.
    Takeuchi H; Thongborisute J; Matsui Y; Sugihara H; Yamamoto H; Kawashima Y
    Adv Drug Deliv Rev; 2005 Nov; 57(11):1583-94. PubMed ID: 16169120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of particle structure of chitosan-coated liposomes and type of chitosan on oral delivery of calcitonin.
    Thongborisute J; Tsuruta A; Kawabata Y; Takeuchi H
    J Drug Target; 2006 Apr; 14(3):147-54. PubMed ID: 16753828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucoadhesive nanoparticulate systems for peptide drug delivery.
    Takeuchi H; Yamamoto H; Kawashima Y
    Adv Drug Deliv Rev; 2001 Mar; 47(1):39-54. PubMed ID: 11251244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucoadhesive intestinal devices for oral delivery of salmon calcitonin.
    Gupta V; Hwang BH; Lee J; Anselmo AC; Doshi N; Mitragotri S
    J Control Release; 2013 Dec; 172(3):753-62. PubMed ID: 24035976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-trimethyl chitosan-modified liposomes as carriers for oral delivery of salmon calcitonin.
    Huang A; Makhlof A; Ping Q; Tozuka Y; Takeuchi H
    Drug Deliv; 2011 Nov; 18(8):562-9. PubMed ID: 21823926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Particle Design Strategies for Developing Patient Centric Dosage Form Preparations].
    Takeuchi H
    Yakugaku Zasshi; 2020; 140(8):1013-1024. PubMed ID: 32741859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved intestinal absorption of calcitonin by mucoadhesive delivery of novel pectin-liposome nanocomplexes.
    Thirawong N; Thongborisute J; Takeuchi H; Sriamornsak P
    J Control Release; 2008 Feb; 125(3):236-45. PubMed ID: 18082282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
    Makhlof A; Werle M; Tozuka Y; Takeuchi H
    J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface modification of liposomes using polymer-wheat germ agglutinin conjugates to improve the absorption of peptide drugs by pulmonary administration.
    Murata M; Yonamine T; Tanaka S; Tahara K; Tozuka Y; Takeuchi H
    J Pharm Sci; 2013 Apr; 102(4):1281-9. PubMed ID: 23389937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats.
    Chen D; Xia D; Li X; Zhu Q; Yu H; Zhu C; Gan Y
    Int J Pharm; 2013 Jun; 449(1-2):1-9. PubMed ID: 23583840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomes coated with thiolated chitosan enhance oral peptide delivery to rats.
    Gradauer K; Barthelmes J; Vonach C; Almer G; Mangge H; Teubl B; Roblegg E; Dünnhaupt S; Fröhlich E; Bernkop-Schnürch A; Prassl R
    J Control Release; 2013 Dec; 172(3):872-8. PubMed ID: 24140721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats.
    Takeuchi H; Matsui Y; Yamamoto H; Kawashima Y
    J Control Release; 2003 Jan; 86(2-3):235-42. PubMed ID: 12526820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Properties of liposomes coated with hydrophobically modified chitosan in oral liposomal drug delivery.
    Thongborisute J; Takeuchi H; Yamamoto H; Kawashima Y
    Pharmazie; 2006 Feb; 61(2):106-11. PubMed ID: 16526556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan-aprotinin coated liposomes for oral peptide delivery: Development, characterisation and in vivo evaluation.
    Werle M; Takeuchi H
    Int J Pharm; 2009 Mar; 370(1-2):26-32. PubMed ID: 19073243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biopharmaceutical approaches for developing and assessing oral peptide delivery strategies and systems: in vitro permeability and in vivo oral absorption of salmon calcitonin (sCT).
    Sinko PJ; Lee YH; Makhey V; Leesman GD; Sutyak JP; Yu H; Perry B; Smith CL; Hu P; Wagner EJ; Falzone LM; McWhorter LT; Gilligan JP; Stern W
    Pharm Res; 1999 Apr; 16(4):527-33. PubMed ID: 10227707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced absorption of insulin and (Asu(1,7))eel-calcitonin using novel azopolymer-coated pellets for colon-specific drug delivery.
    Tozaki H; Nishioka J; Komoike J; Okada N; Fujita T; Muranishi S; Kim SI; Terashima H; Yamamoto A
    J Pharm Sci; 2001 Jan; 90(1):89-97. PubMed ID: 11064382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions.
    Yamamoto H; Kuno Y; Sugimoto S; Takeuchi H; Kawashima Y
    J Control Release; 2005 Feb; 102(2):373-81. PubMed ID: 15653158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption-improving effects of chitosan oligomers based on their mucoadhesive properties: a comparative study on the oral and pulmonary delivery of calcitonin.
    Zhang H; Huang X; Sun Y; Xing J; Yamamoto A; Gao Y
    Drug Deliv; 2016 Sep; 23(7):2419-2427. PubMed ID: 25594571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.